A faculty investigator at HudsonAlpha Institute for Biotechnology, a member of the Breast Cancer Research Foundation of Alabama’s Medical Advisory Council, is focusing her research on understanding cancer pathology, progression and chemoresistance to personalize cancer diagnosis and treatment.
Dr. Sara Cooper has been working with the BCRFA since 2016, when the nonprofit foundation – which funds the leading breast cancer research in Alabama – provided a grant to HudsonAlpha and the University of Alabama at Birmingham for a collaborative research project to study biomarkers in immunotherapy.
(I
HALO NEWSLETTER
Keep reading HALO with a Free Subscription
unlock this story instantly and join members and pros reading HALO daily
-It's
Free
Halo
